TipRanks
Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR
US Market
LRMR
Larimar Therapeutics
RESEARCH TOOLSreports
Want to see LRMR full AI Analyst Report?

Larimar Therapeutics (LRMR) Stock News & Sentiment

1,155 Followers
Larimar Therapeutics Appoints New President and COO
Premium
Company Announcements
Larimar Therapeutics Appoints New President and COO
5d ago
8K
LRMR
Larimar’s CTI-1601 Study Update Keeps Friedreich’s Ataxia Catalyst in Play
Premium
Company Announcements
Larimar’s CTI-1601 Study Update Keeps Friedreich’s Ataxia Catalyst in Play
1M ago
LRMR
Larimar’s Phase 3 Friedreich’s Ataxia Trial Puts Nomlabofusp in the Investor Spotlight
Premium
Company Announcements
Larimar’s Phase 3 Friedreich’s Ataxia Trial Puts Nomlabofusp in the Investor Spotlight
1M ago
LRMR
Larimar Therapeutics: Buy Rating Reaffirmed as FDA-Backed Nomlabofusp Progress Supports Unchanged $25 Price Target
Premium
Ratings
Larimar Therapeutics: Buy Rating Reaffirmed as FDA-Backed Nomlabofusp Progress Supports Unchanged $25 Price Target
2M ago
LRMR
Analyst Sees Larimar as Undervalued on Nomlabofusp’s Strong Efficacy and On‑Track BLA, Reiterates Buy Rating Ahead of 2027 FA Launch
Premium
Ratings
Analyst Sees Larimar as Undervalued on Nomlabofusp’s Strong Efficacy and On‑Track BLA, Reiterates Buy Rating Ahead of 2027 FA Launch
2M ago
LRMR
Regulatory and Manufacturing Risks Cloud Larimar Therapeutics’ Accelerated Approval Path for Nomlabofusp
Premium
Company Announcements
Regulatory and Manufacturing Risks Cloud Larimar Therapeutics’ Accelerated Approval Path for Nomlabofusp
2M ago
LRMR
Larimar reports Q2 results and nomlabofusp progress
Premium
Company Announcements
Larimar reports Q2 results and nomlabofusp progress
2M ago
8K
LRMR
More LRMR News >

LRMR News on the Web

Larimar Therapeutics Names John Harlow As President And COO
rttnews
Neutral
Larimar Therapeutics Appoints New President and COO
TipRanks News
Neutral
Larimar Therapeutics appoints John Harlow as COO
TipRanks News
Bullish
Analyst Sees Larimar as Undervalued on Nomlabofusp’s Strong Efficacy and On‑Track BLA, Reiterates Buy Rating Ahead of 2027 FA Launch
TipRanks News
Bullish
Regulatory and Manufacturing Risks Cloud Larimar Therapeutics’ Accelerated Approval Path for Nomlabofusp
TipRanks News
Bearish
Buy Rating Reaffirmed on Growing Nomlabofusp Confidence; $25 Price Target Maintained
TipRanks News
Bullish
Larimar, Cytokinetics, Itau, Global-e, Immunovant Shake-Up
TipRanks News
Bullish
Insider Move: Larimar Therapeutics Director Makes Bold New Stock Purchase
TipRanks News
Neutral

News Score - Last 7 Days

Positive
LRMR
Sector Average
Media Buzz
This Week4 articles
Weekly Average0.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LRMR’s Media Buzz Sentiment?
4 articles about LRMR were published this week. In an average week, 0.5 articles are published.
    What is LRMR’s weekly average amount of articles?
    In an average week, 0.5 articles about LRMR are published.
      What is LRMR’s News Sentiment?
      100% of articles about LRMR were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        RHHBYRoche Holding
        BAYRYBayer
        SNYSanofi
        CICigna
        TFXTeleflex
        Showing the stocks with the most bullish news sentiment over the past week